Plano, Texas-based Integer Holdings (NYSE:ITGR), a leading outsource manufacturer of medical devices and components, reported fourth-quarter net income of $48.6 million, or $1.38 per share, for the period ended December 2025.
When adjusted for one-time gains and costs, earnings reached $1.76 per share, surpassing the average analyst estimate of $1.70 per share from seven analysts surveyed by Zacks Investment Research.
Revenue for the quarter climbed to $472.1 million, exceeding Street forecasts of $462.6 million from the same seven analysts.
The top-line beat reflected continued robust demand across Integer's core markets, including electrophysiology, structural heart, neuromodulation, and vascular access.
For the full year 2025, Integer reported net income of $102.8 million, or $2.89 per share, on revenue of $1.85 billion.
Looking forward, Integer provided 2026 guidance projecting adjusted earnings per share in the range of $6.29 to $6.78, with revenue expected between $1.83 billion and $1.88 billion.